Relafen 750, biologically known as naproxen, showcases a fascinating case study within the cellular pharmacy domain . Its mode of function copyrights on inhibiting cyclooxygenase proteins, specifically COX-1 and COX-2, thereby reducing the production of prostaglandins, which are vital mediators of inflammation and heat. This targeted inhibition off